Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Non-cash Items (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Non-cash Items for 3 consecutive years, with $264000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non-cash Items changed N/A to $264000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $264000.0, a N/A change, with the full-year FY2025 number at $264000.0, changed N/A from a year prior.
  • Non-cash Items was $264000.0 for Q4 2025 at Spruce Biosciences, down from $3.0 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $3.0 million in Q4 2023 to a low of $52000.0 in Q4 2022.
  • A 3-year average of $735333.3 and a median of $337000.0 in 2022 define the central range for Non-cash Items.
  • Biggest YoY gain for Non-cash Items was 5765.38% in 2023; the steepest drop was 5765.38% in 2023.
  • Spruce Biosciences' Non-cash Items stood at $52000.0 in 2022, then surged by 5765.38% to $3.0 million in 2023, then tumbled by 91.34% to $264000.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Non-cash Items are $264000.0 (Q4 2025), $3.0 million (Q4 2023), and $52000.0 (Q4 2022).